Isotechnika Pharma Inc IPHAF

RE: Just my little bit.

[narcissist]

I am not sure anyone is much of a fancy investor around here. The trouble with this whole business of researching any promising stock are the mutiple layers of spin covering all pronouncements about the potential of the business. The only area where I feel remotely comfortable about a stock is where that stock's main product has been independently assessed. Voclosporin has been assessed at arm's length from the company, and has been pronounced "promising."  Because this isn't Bob Foster or some other ISA mouthpiece spouting propaganda, I can trust those pronouncements - to a degree. That frankly is all I can say - other than there is a potentially huge market - in excess of $3-4 billion. If the "promising" ever turns into actuality, and the product taps into that huge market, the share value of ISA might one day climb. But, as has been said over and over here, "promising" will never become a certainty until there is a large scale phase 3 clinical trial. And as of today that just ain't happening. Why? I have no idea. Perhaps we are being scammed. Perhaps the nay sayers on this board have been right all along. Perhaps we are all fools. Perhaps. I think though that the next few months will tell the tale. ISA has to pony up with support for a meaningful Clinical trial. If we don't see that before summer I think the best strategy would be to pull out.